
Research at ObesityWeek 2026 tracks rising obesity in Medicare, productivity losses, prior authorization denials, and GLP-1 persistence.
https://www.pharmacytimes.org/on-demand/examining-the-application-of-immunoglobulin-in-multiple-disease-states-a-review-of-evidence





